+86-0755 2308 4243
Cyclo (RGDfK)

Cyclo (RGDfK)

Tus lej naj npawb: BRS16049

Cyclo(-RGDfK) yog ib qho muaj zog thiab xaiv inhibitor ntawm v3 integrin, nrog IC50 ntawm 0.94 nM[1]. [(66)Ga]DOTA-E-[c(RGDfK)]2 can be prepared with high radiochemical purity (>97%), kev ua haujlwm tshwj xeeb (36-67GBq/μM), nyob rau hauv vitro stability, thiab muaj protein ntau khi. MicroPET imaging mus txog 24 tom qab txhaj tshuaj tau pom qhov sib txawv ntawm cov qog uas cuam tshuam v 3-targeted tracer accumululation[2].

 

Specifications

Sequence ib tsab ntawv code

cyclo (RGDfK)

Sequence peb tsab ntawv code

cyclo(-Arg-Gly-Asp-D-Ph-Lys)

CAS Nr

161552-03-0

Molecular Formula

C27H41N9O7

Molecular Luj

603.68

Kev hloov kho

N/A

Purity

Peak Area los ntawm HPLC Ntau dua lossis sib npaug li 98%

Daim ntawv

Lyophilized

Ntev Cia

- 20℃lossis qis dua

Rau kev tshawb fawb siv nkaus xwb.

 

Cov ntaub ntawv:
1. Simecek J, et al. Cov txiaj ntsig ntawm NOPO li chelator hauv gallium-68 peptides, ua piv txwv los ntawm preclinical characterization ntawm (68)Ga-NOPO-c(RGDfK). Mol Pharm. 2014 Tsib Hlis 5; 11(5): 1687-95.
2. Lopez-Rodriguez V, et al. Kev npaj thiab kev soj ntsuam ua ntej ntawm (66)Ga-DOTA-E(c(RGDfK))2 raws li qhov muaj peev xwm theranostic radiopharmaceutical. Nucl Med Biol. 2015 Feb;42(2):109-14.

 

Cim npe nrov: cyclo (RGDfK)

Cov ntaub ntawv
COA. ua pdf
HPLC. ua pdf
MS. ua pdf

Citations
Yam khoom

Koj Tseem Yuav Zoo Li

Xa kev nug

(0/10)

clearall